ReachMD

Be part of the knowledge.™

Women's Health

555

LikeLikedUnlike

Episodes 1-15 of 53

- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Barbara Dehn
  Peer
3
CME/CE
Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability
Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability
0.25 credits
- Javed Butler, MD, MPH, MBA
  Peer
- Paul W. Armstrong, MD
  Peer
1
CME/CE
New Therapies Offer Improved Outcomes in HFrEF Management
New Therapies Offer Improved Outcomes in HFrEF Management
0.25 credits
- Floor J. Backes, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
2
CME/CE
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
0.25 credits
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
2
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
- Charles E. Geyer, Jr., MD, FACP
  Peer
- Hope S. Rugo, MD
  Peer
1
CME/CE
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
Evolving Strategies in the Management of HER2-Positive Early-Stage Breast Cancer
0.25 credits
- Joel L. Cohen, MD
  Peer
- Jason D. Bloom, MD
  Peer
0
CME/CE
Neuromodulator Dosing for the Upper Face
Neuromodulator Dosing for the Upper Face
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Andrew M. Kaunitz, MD, FACOG
  Peer
13
CME/CE
New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)
New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)
0.25 credits
- Joel L. Cohen, MD
  Peer
- Carolyn I. Jacob, MD, FAAD
  Peer
7
CME/CE
Neuromodulator Dosing for Duration
Neuromodulator Dosing for Duration
0.25 credits
- Andrew Alexis, MD, MPH
  Peer
- Linda Stein Gold, MD
  Peer
0
CME/CE
Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes
Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Anita L. Nelson, MD
  Peer
18
CME/CE
The Evolution of Estrogen in Contraception—From E1 to E4
The Evolution of Estrogen in Contraception—From E1 to E4
0.25 credits
- Brendan J. Canning, PhD
  Peer
- Peter Dicpinigaitis, MD
  Peer
9
CME/CE
Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough
Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough
0.25 credits
- Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
  Peer
- Peter Pickkers, MD, PhD
  Peer
- Alexander Zarbock, MD
  Peer
10
CME/CE
Cases in Acute Kidney Injury: Applications for Clinical Practice
Cases in Acute Kidney Injury: Applications for Clinical Practice
0.25 credits
- Peter Dicpinigaitis, MD
  Peer
- Brendan J. Canning, PhD
  Peer
9
CME/CE
Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto Itself
Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto Itself
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- David J. Portman, MD
  Peer
12
CME/CE
Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch
Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch
0.25 credits
- David J. Portman, MD
  Peer
9
CME/CE Broadcast Replay
The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions
The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions
0.50 credits

Programs 4/10/21

Segment Chapters

Playlist:

Recommended